<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03730610</url>
  </required_header>
  <id_info>
    <org_study_id>317332</org_study_id>
    <nct_id>NCT03730610</nct_id>
  </id_info>
  <brief_title>Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Effects of Exercise Training</brief_title>
  <acronym>CROSSYS</acronym>
  <official_title>Modelling Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Exercise Training and Public Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Helsinki</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finnish Cultural Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Diabetes Research Foundation, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Juho Vainio Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity and insulin resistance are worldwide epidemic and taking a major public health toll.&#xD;
      Obesity also increases the risk for cognitive impairment which is also an increasing medical,&#xD;
      societal, and economic challenge. The ultimate goal of this proposal is to develop a&#xD;
      statistical model to assess systemic cross-talk between brain, peripheral tissues, gut&#xD;
      microbiota and glucose metabolism. Integrated with exercise training intervention the results&#xD;
      will be utilized to provide disease risk profiling and personalized predictions of exercise&#xD;
      training as a drug free treatment for insulin resistance and type 2 diabetes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 30, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Exercise Training for six months</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of exercise training - brain glucose uptake</measure>
    <time_frame>The change from baseline to 6 months</time_frame>
    <description>Brain glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with [18F]-labelled fluoro-deoxy-glucose (FDG) tracer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of exercise training - brain inflammation</measure>
    <time_frame>The change from baseline to 6 months</time_frame>
    <description>Brain inflammation (dimensionless; standistibution volume ratio) is measured with positron emission tomography (PET) with PK11195 tracer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects of exercise training - liver glucose uptake</measure>
    <time_frame>The change from baseline to 6 months</time_frame>
    <description>Liver glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with [18F]-labelled fluoro-deoxy-glucose (FDG) tracer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of exercise training - adipose tissue glucose uptake</measure>
    <time_frame>The change from baseline to 6 months</time_frame>
    <description>Adipose tissue glucose uptake (micromol/100g/min) is measured with positron emission tomography (PET) with [18F]-labelled fluoro-deoxy-glucose (FDG) tracer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of exercise training - whole-body insulin sensitivity</measure>
    <time_frame>The change from baseline to 6 months</time_frame>
    <description>Whole-body insulin sensitivity (M-value; micromol/100g/min) during the hyperinsulinemic euglycemic clamp</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of exercise training - ectopic fat</measure>
    <time_frame>The change from baseline to 6 months</time_frame>
    <description>Ectopic fat content (%) is measured using magnetic resonance spectroscopy (MRS)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <condition>Type2 Diabetes</condition>
  <condition>Exercise Training</condition>
  <arm_group>
    <arm_group_label>Exercise intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six months of exercise training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>Subjects are required to exercise four times a week during six months. Exercise training consists of endurance training, resistance training and high-intensity interval training adjusted to subject's fitness level.</description>
    <arm_group_label>Exercise intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  monozygotic twins&#xD;
&#xD;
          -  body mass index (BMI) difference â‰¥ 2 kg/m2 and/or type 2 diabetes&#xD;
&#xD;
          -  At least one co-twin is overweight (BMI &gt; 25 kg/m2)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt; 60 kg/m2&#xD;
&#xD;
          -  body weight &gt; 170 kg&#xD;
&#xD;
          -  waist circumference &gt; 150 cm&#xD;
&#xD;
          -  mental disorder or poor compliance&#xD;
&#xD;
          -  eating disorder or excessive use of alcohol&#xD;
&#xD;
          -  active ulcus disease&#xD;
&#xD;
          -  diabetes requiring insulin treatment or fasting glucose &gt; 10 mmol/l&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  past dose of radiation&#xD;
&#xD;
          -  claustrophobia&#xD;
&#xD;
          -  presence of ferromagnetic objects that would make MRI contraindicated&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jarna Hannukainen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku PET Cente, University of Turku, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Turku</name>
      <address>
        <city>Turku</city>
        <zip>20540</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 31, 2018</study_first_submitted>
  <study_first_submitted_qc>November 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2018</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turku</investigator_affiliation>
    <investigator_full_name>Jarna Hannukainen</investigator_full_name>
    <investigator_title>Adjunct Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD of the main outcome measures will be opened if possible to such as extent that individuals cannot be identified.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

